세계의 반려동물 관절염 시장 보고서(2025년)
Companion Animal Arthritis Global Market Report 2025
상품코드 : 1793351
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

반려동물 관절염 시장 규모는 앞으로 몇 년 동안 급성장할 것으로 예측됩니다. 2029년에는 CAGR 10.2%를 나타내 60억 달러로 성장할 전망입니다. 예측 기간의 성장은 반려동물의 노화, 치료제의 혁신, 맞춤형 영양, 동물 의료에서의 원격 의료, 반려동물의 인간화 등에 기인합니다. 예측기간의 주요 동향으로는 동물의료에 있어서의 생물제제, 디지털 헬스 솔루션, 영양보조식품과 기능성식품, 제휴와 파트너십, 반려동물 보험에 대한 영향, 자연요법과 홀리스틱요법에 대한 소비자 수요, 데이터 구동형 동물의료 등이 있습니다.

향후 5년간의 성장률 10.2%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 노르웨이산 오메가 3계 어유 캡슐의 관세는 개·고양이용의 고관절용 보충제의 원재료비를 밀어 올립니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

반려동물 사육 동향 증가는 반려동물 관절염 시장 성장을 가속할 것으로 예측됩니다. 반려동물 입양은 스트레스, 불안, 우울증 등을 완화하는 데 도움이 됩니다. 반려동물 입양은 반려동물 가게와 브리더, 다른 개인으로부터 기르는 것이 아니라, 이전의 주인이 보호 시설이나 구조에 풀어 놓은 개나 고양이, 기타 이국적인 동물을 기르는 방법입니다. 반려동물은 나이가 들면 관절염을 개발할 위험에 직면합니다. 예를 들어 미국에 본사를 둔 비영리 산업 단체인 미국 반려동물 용품협회가 실시한 조사에 따르면 영국에서 반려동물을 키우는 가정의 약 절반이 나라가 봉쇄되어 있는 동안 적어도 한 마리의 새로운 반려동물을 키우기 시작했고, 1,130만 명의 미국인이 유행기간 동안 새로운 반려동물을 키우기 시작했습니다. 게다가 이 연구는 Z세대 응답자의 16%와 밀레니얼 세대의 13%가 유행 중에 새로운 반려동물을 키웠다고 답했습니다. 그러므로 반려동물 사육 동향 증가는 반려동물 관절염 시장 성장에 크게 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

The companion animal arthritis refers to a condition involving inflammation of one or more joints in companion animals such as cats, dogs, and other exotic animals. Companion animal arthritis develops in the bones when the cartilage between joints becomes rougher and more worn, forcing the bone surfaces to rub against one another.

The main type of companion animal arthritis are dogs, cats, and others types. The dogs companion animal arthritis are used for controlling pain and inflammation in dogs. Dogs are domesticated canines (Canis familiaris) that are usually kept as pets or trained for hunting, guarding individuals or property. The companion animal arthritis indication are osteoarthritis and, other arthritis, that are treatment through medication, supplements and other treatment, which are sold and distributed through veterinary hospitals and clinics, retail pharmacies, online stores, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The companion animal arthritis market research report is one of a series of new reports from The Business Research Company that provides companion animal arthritis market statistics, including companion animal arthritis industry global market size, regional shares, competitors with a companion animal arthritis market share, detailed companion animal arthritis market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal arthritis industry. This companion animal arthritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal arthritis market size has grown strongly in recent years. It will grow from $3.72 billion in 2024 to $4.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing pet ownership, advancements in veterinary medicine, awareness, and education.

The companion animal arthritis market size is expected to see rapid growth in the next few years. It will grow to $6 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to aging pet population, innovations in therapeutics, customized nutrition, telemedicine in veterinary care, humanization of pets. Major trends in the forecast period include biologics in veterinary medicine, digital health solutions, nutraceuticals and functional foods, collaborations and partnerships, pet insurance impact, consumer demand for natural and holistic therapies, data-driven veterinary care.

The forecast of 10.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on Norwegian omega-3 fish-oil capsules will swell ingredient costs for hip-and-joint supplements aimed at dogs and cats. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Rising trend of pet adoption is expected to propel the growth of companion animal arthritis market. Pet adoption helps reduce stress, anxiety, depression, and so on. Pet adoption is a method of getting a dog, cat, and other exotic animals that their prior owners have given up to a shelter or rescue rather than getting one from a pet shop, breeder, or another individual. Pets face the risk of developing arthritis once they start getting into old age. For instance, according to a survey conducted by, The American Pet Products Association, a US-based not-for-profit industry association, approximately half of british homes with pets acquired at least one new animal while the country was in lockdown, while 11. 3 million Americans acquired new pets during the pandemic. Additionally, in the survey, 16% of Generation Z respondents and 13% of millennials stated they had adopted a new pet during the pandemic. Therefore, the rising trend of pet adoption contributes significantly to the growth of the companion animal arthritis market.

The increased spending on pet healthcare is anticipated to boost the demand for the companion animal arthritis market over the coming years. Spending on pet healthcare refers to the financial outlay for medical services and treatments aimed at maintaining or improving the well-being of domestic animals. Spending on companion animal arthritis care has risen steadily, reflecting a growing commitment to improving pets' well-being and quality of life. For instance, in 2022, according to the American Pet Products Association Inc., a US-based not-for-profit industry association, the expenditure on supplies, live animals, and OTC medicine is $31. 5 billion in 2022 compared to $32. 1 billion in 2023 and expenditure on veterinary care and products is $35. 9 billion in 2022 compared to 37 billion in 2023. Therefore, increased spending on pet healthcare is driving the growth of the companion animal arthritis market.

Leading companies in the companion animal arthritis market are increasingly concentrating on technological innovations, including advanced therapeutic products and supplements, to provide pets with effective pain relief and improved joint health, ultimately enhancing the quality of life for aging and arthritis-affected animals. One notable example is Bonqat, a new medication designed for cats that helps reduce anxiety during stressful situations, such as travel or veterinary visits, without causing sedation. This product aims to soothe cats, making it easier for both pets and their owners during trips or appointments. For instance, in April 2024, Zoetis Inc., a US-based company specializing in medicines and vaccinations for pets and livestock, launched Bonqat (pregabalin oral solution) to alleviate feline acute anxiety and fear associated with transportation and veterinary visits, which can hinder routine care. The oral solution can be mixed with food or administered directly to the cat, simplifying the process for pet owners. The dosing is minimal (0.1 mL/kg), and many cat owners have reported that administration is straightforward.

Major companies operating in the companion animal arthritis market are focused on developing stem cell treatments to gain a competitive edge in the market. Stem cell treatment is being explored as a promising therapy for animal arthritis, offering potential relief and regeneration of damaged joints. For instance, in January 2023, TVM, a UK-based animal health company, introduced DogStem, the first and only licensed stem cell therapy for canine osteoarthritis in Europe. This innovative treatment is designed for dogs with mild to severe hip and elbow osteoarthritis, and it has demonstrated effectiveness in reducing pain, alleviating lameness, and enhancing mobility and overall quality of life. DogStem boasts long-term efficacy, providing relief for dogs lasting anywhere from 3 to more than 12 months after a single injection. The key active ingredient in this product is mesenchymal stem cells derived from equine umbilical cords, known for their immunomodulatory and anti-inflammatory properties attributed to their paracrine activity.

In September 2022, Zoetis, a US-based animal health company, acquired NewMetrica for an undisclosed amount. This transaction would enhance Zoetis' capacities throughout the continuum of care, expand our grasp of quality-of-life evaluations, and result in a more profound comprehension of an animal's well-being. NewMetrica is a UK-based provider of scientifically-developed instruments to measure quality-of-life in animals such as canine arthritis.

Major companies operating in the companion animal arthritis market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Synlogic, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Pawsitively Posh Pets, Trifecta Natural, Nutramax Laboratories, Hill's Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Fetch for Pets, Lintbells, Allivet, Petlab Co.

North America was the largest region in the companion animal arthritis market in 2024. The regions covered in the companion animal arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the companion animal arthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The companion animal arthritis market includes revenues earned by entities by NSAIDs, monoclonal antibiotics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Arthritis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal arthritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for companion animal arthritis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The companion animal arthritis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Companion Animal Arthritis Market Characteristics

3. Companion Animal Arthritis Market Trends And Strategies

4. Companion Animal Arthritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Companion Animal Arthritis Growth Analysis And Strategic Analysis Framework

6. Companion Animal Arthritis Market Segmentation

7. Companion Animal Arthritis Market Regional And Country Analysis

8. Asia-Pacific Companion Animal Arthritis Market

9. China Companion Animal Arthritis Market

10. India Companion Animal Arthritis Market

11. Japan Companion Animal Arthritis Market

12. Australia Companion Animal Arthritis Market

13. Indonesia Companion Animal Arthritis Market

14. South Korea Companion Animal Arthritis Market

15. Western Europe Companion Animal Arthritis Market

16. UK Companion Animal Arthritis Market

17. Germany Companion Animal Arthritis Market

18. France Companion Animal Arthritis Market

19. Italy Companion Animal Arthritis Market

20. Spain Companion Animal Arthritis Market

21. Eastern Europe Companion Animal Arthritis Market

22. Russia Companion Animal Arthritis Market

23. North America Companion Animal Arthritis Market

24. USA Companion Animal Arthritis Market

25. Canada Companion Animal Arthritis Market

26. South America Companion Animal Arthritis Market

27. Brazil Companion Animal Arthritis Market

28. Middle East Companion Animal Arthritis Market

29. Africa Companion Animal Arthritis Market

30. Companion Animal Arthritis Market Competitive Landscape And Company Profiles

31. Companion Animal Arthritis Market Other Major And Innovative Companies

32. Global Companion Animal Arthritis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Arthritis Market

34. Recent Developments In The Companion Animal Arthritis Market

35. Companion Animal Arthritis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기